These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 24172787)

  • 21. Diagnostic accuracy of diffusion-weighted MRI for differentiation of cervical cancer and benign cervical lesions at 3.0T: Comparison with routine MRI and dynamic contrast-enhanced MRI.
    Kuang F; Yan Z; Li H; Feng H
    J Magn Reson Imaging; 2015 Oct; 42(4):1094-9. PubMed ID: 25824638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Semi-quantitative and quantitative dynamic contrast-enhanced (DCE) MRI parameters as prostate cancer imaging biomarkers for biologically targeted radiation therapy.
    Reynolds HM; Tadimalla S; Wang YF; Montazerolghaem M; Sun Y; Williams S; Mitchell C; Finnegan ME; Murphy DG; Haworth A
    Cancer Imaging; 2022 Dec; 22(1):71. PubMed ID: 36536464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
    Kim CK; Park BK; Lee HM; Kwon GY
    Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of apparent diffusion coefficient calculation between two-point and multipoint B value analyses in prostate cancer and benign prostate tissue at 3 T: preliminary experience.
    Park SY; Kim CK; Park BK; Kwon GY
    AJR Am J Roentgenol; 2014 Sep; 203(3):W287-94. PubMed ID: 25148186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Added value of diffusion-weighted images and dynamic contrast enhancement in multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer in the PICTURE trial.
    Eldred-Evans D; Neves JB; Simmons LAM; Kanthabalan A; McCartan N; Shah TT; Arya M; Charman SC; Freeman A; Moore CM; Punwani S; Emberton M; Ahmed HU
    BJU Int; 2020 Mar; 125(3):391-398. PubMed ID: 31733173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apparent diffusion coefficient of line scan diffusion image in normal prostate and prostate cancer--comparison with single-shot echo planner image.
    Yoshizako T; Wada A; Uchida K; Hara S; Igawa M; Kitagaki H; Maier SE
    Magn Reson Imaging; 2011 Jan; 29(1):106-10. PubMed ID: 20833498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced Diffusion-weighted Imaging Modeling for Prostate Cancer Characterization: Correlation with Quantitative Histopathologic Tumor Tissue Composition-A Hypothesis-generating Study.
    Hectors SJ; Semaan S; Song C; Lewis S; Haines GK; Tewari A; Rastinehad AR; Taouli B
    Radiology; 2018 Mar; 286(3):918-928. PubMed ID: 29117481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T2* mapping combined with conventional T2-weighted image for prostate cancer detection at 3.0T MRI: a multi-observer study.
    Wu LM; Yao QY; Zhu J; Lu Q; Suo ST; Liu Q; Xu JR; Chen XX; Haacke EM; Hu J
    Acta Radiol; 2017 Jan; 58(1):114-120. PubMed ID: 26917785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging.
    Panebianco V; Barchetti F; Sciarra A; Musio D; Forte V; Gentile V; Tombolini V; Catalano C
    Eur Radiol; 2013 Jun; 23(6):1745-52. PubMed ID: 23377546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-resolution prostate diffusion MRI using eddy current-nulled convex optimized diffusion encoding and random matrix theory-based denoising.
    Zhang Z; Aygun E; Shih SF; Raman SS; Sung K; Wu HH
    MAGMA; 2024 Aug; 37(4):603-619. PubMed ID: 38349453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension.
    Rosenkrantz AB; Chandarana H; Gilet A; Deng FM; Babb JS; Melamed J; Taneja SS
    J Magn Reson Imaging; 2013 Aug; 38(2):312-9. PubMed ID: 23238968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical utility of apparent diffusion coefficient values obtained using high b-value when diagnosing prostate cancer using 3 tesla MRI: comparison between ultra-high b-value (2000 s/mm²) and standard high b-value (1000 s/mm²).
    Kitajima K; Takahashi S; Ueno Y; Yoshikawa T; Ohno Y; Obara M; Miyake H; Fujisawa M; Sugimura K
    J Magn Reson Imaging; 2012 Jul; 36(1):198-205. PubMed ID: 22371381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.
    Rosenkrantz AB; Kong X; Niver BE; Berkman DS; Melamed J; Babb JS; Taneja SS
    AJR Am J Roentgenol; 2011 Jan; 196(1):123-9. PubMed ID: 21178056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High and ultra-high b-value diffusion-weighted imaging in prostate cancer: a quantitative analysis.
    Wetter A; Nensa F; Lipponer C; Guberina N; Olbricht T; Schenck M; Schlosser TW; Gratz M; Lauenstein TC
    Acta Radiol; 2015 Aug; 56(8):1009-15. PubMed ID: 25168023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of stretched-Exponential and monoexponential model diffusion-Weighted imaging in prostate cancer and normal tissues.
    Liu X; Zhou L; Peng W; Wang H; Zhang Y
    J Magn Reson Imaging; 2015 Oct; 42(4):1078-85. PubMed ID: 25727776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy.
    Roy C; Foudi F; Charton J; Jung M; Lang H; Saussine C; Jacqmin D
    AJR Am J Roentgenol; 2013 Apr; 200(4):W361-8. PubMed ID: 23521479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume.
    Mazaheri Y; Hricak H; Fine SW; Akin O; Shukla-Dave A; Ishill NM; Moskowitz CS; Grater JE; Reuter VE; Zakian KL; Touijer KA; Koutcher JA
    Radiology; 2009 Aug; 252(2):449-57. PubMed ID: 19703883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
    Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
    Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system.
    Quentin M; Arsov C; Röhlen S; Klasen J; Antoch G; Albers P; Blondin D
    Rofo; 2012 Oct; 184(10):925-9. PubMed ID: 22744328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.